Article Menu
Need Help?
No Article Versions Notes Found
Cite
Chia, S.; Gandhi, S.; Joy, A.A.; Edwards, S.; Gorr, M.; Hopkins, S.; Kondejewski, J.; Ayoub, J.P.; Califaretti, N.; Rayson, D.; et al. Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast Cancer. Curr. Oncol. 2015, 22, 33-48. https://doi.org/10.3747/co.22.2393
Chia S, Gandhi S, Joy AA, Edwards S, Gorr M, Hopkins S, Kondejewski J, Ayoub JP, Califaretti N, Rayson D, et al. Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast Cancer. Current Oncology. 2015; 22(1):33-48. https://doi.org/10.3747/co.22.2393
Chicago/Turabian StyleChia, S., S. Gandhi, A.A. Joy, S. Edwards, M. Gorr, S. Hopkins, J. Kondejewski, J.P. Ayoub, N. Califaretti, D. Rayson, and et al. 2015. "Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast Cancer" Current Oncology 22, no. 1: 33-48. https://doi.org/10.3747/co.22.2393